Catalyst Capital Advisors’s Inspire Medical Systems INSP Stock Holding History

Catalyst Capital Advisors’s Portfolio INSP Stock Details INSP Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q4	–	Sell	-224	Closed	-$14K	–	360
2019 Q3	$14K	Hold	224	–	–	﹤0.01%	320
2019 Q2	$14K	Hold	224	–	–	﹤0.01%	290
2019 Q1	$13K	Sell	224 -50	-18%	-$2.7K	﹤0.01%	281
2018 Q4	$12K	Hold	274	–	–	﹤0.01%	293
2018 Q3	$12K	Hold	274	–	–	﹤0.01%	324
2018 Q2	$10K	Buy	+274	New	+$8.84K	﹤0.01%	360

Other funds holding INSP

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return

William Blair Investment Management Chicago, Illinois $30.3B AUM 33.75% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Lord, Abbett & Co Jersey City, New Jersey $30.6B AUM 57.44% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

CCI

Columbus Circle Investors $2.28B AUM 135.57% 1-Year Est. Return

CIP

Champlain Investment Partners Burlington, Vermont $7.88B AUM 6.82% 1-Year Est. Return

Catalyst Capital Advisors's INSP Position: Q4 2019 in Review

Catalyst Capital Advisors sold out of Inspire Medical Systems (INSP) in Q4 2019, closing a stake of 224 shares — an estimated $14K sold.

Catalyst Capital Advisors first reported a position in INSP in Q2 2018 and held it in 6 quarters. The position peaked at $14K in Q3 2019. 171 funds tracked by Wall St. Rank hold INSP as of Q4 2019.

Catalyst Capital Advisors reported no remaining Inspire Medical Systems position as of Q4 2019 after selling out during the quarter.
Catalyst Capital Advisors sold 224 Inspire Medical Systems shares in Q4 2019, an estimated $14K.
Catalyst Capital Advisors first reported a position in Inspire Medical Systems in Q2 2018 and held it in 6 quarters.
Catalyst Capital Advisors's Inspire Medical Systems position peaked at $14K in Q3 2019.
171 funds tracked by Wall St. Rank held Inspire Medical Systems as of Q4 2019.

Based on Catalyst Capital Advisors's 13F filing for Q4 2019, filed 6 Feb 2020.